Nrg Oncology
Clinical trials sponsored by Nrg Oncology, explained in plain language.
-
Liver cancer radiation trial halted after just one patient
Disease control TerminatedThis study aimed to see if adding focused radiation to standard chemotherapy could help people with a type of liver cancer that cannot be surgically removed. Only one person enrolled before the trial was stopped early, so no meaningful conclusions could be drawn. The approach com…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 17, 2026 08:21 UTC
-
Bladder cancer radiation trial stopped early
Disease control TerminatedThis study looked at whether giving radiation therapy after bladder removal surgery could help prevent cancer from coming back in the pelvis. It included 14 people with advanced bladder cancer. The trial was stopped early, so we don't have clear answers on whether the radiation h…
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 17, 2026 08:21 UTC
-
Mesothelioma radiation trial halted early – only 16 patients enrolled
Disease control TerminatedThis study looked at whether adding targeted radiation to the chest after surgery and chemotherapy could help people with early-stage malignant pleural mesothelioma live longer. The trial was stopped early and only enrolled 16 participants, so it is not clear if the radiation pro…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 17, 2026 08:16 UTC
-
Step counts may help lung cancer patients avoid hospital stays
Symptom relief TerminatedThis study looked at whether monitoring daily step counts in people with locally advanced non-small cell lung cancer during chemoradiotherapy could help doctors provide better supportive care and reduce hospital visits or treatment delays. Only 3 participants were enrolled before…
Phase: NA • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC